FDG PET/computed tomography can detect region-specific neuronal changes following antiretroviral therapy in HIV-infected patients
- PMID: 34076617
- DOI: 10.1097/QAD.0000000000002925
FDG PET/computed tomography can detect region-specific neuronal changes following antiretroviral therapy in HIV-infected patients
Comment on
-
Redistribution of brain glucose metabolism in people with HIV after antiretroviral therapy initiation.AIDS. 2021 Jul 1;35(8):1209-1219. doi: 10.1097/QAD.0000000000002875. AIDS. 2021. PMID: 33710014 Free PMC article.
Similar articles
-
FDG PET/CT in patients with HIV.AJR Am J Roentgenol. 2011 Aug;197(2):284-94. doi: 10.2214/AJR.10.6332. AJR Am J Roentgenol. 2011. PMID: 21785073 Review.
-
Role and interpretation of fluorodeoxyglucose-positron emission tomography/computed tomography in HIV-infected patients with fever of unknown origin: a prospective study.HIV Med. 2013 Sep;14(8):455-62. doi: 10.1111/hiv.12030. Epub 2013 Mar 20. HIV Med. 2013. PMID: 23517190
-
Immune reconstitution inflammatory syndrome due to Mycobacterium avium complex successfully followed up using 18 F-fluorodeoxyglucose positron emission tomography-computed tomography in a patient with human immunodeficiency virus infection: A case report.BMC Med Imaging. 2015 Jul 18;15:24. doi: 10.1186/s12880-015-0063-2. BMC Med Imaging. 2015. PMID: 26187282 Free PMC article.
-
FDG-PET imaging in HIV infection and tuberculosis.Semin Nucl Med. 2013 Sep;43(5):349-66. doi: 10.1053/j.semnuclmed.2013.04.008. Semin Nucl Med. 2013. PMID: 23905617 Review.
-
Contribution of 18F-FDG PET/CT imaging in the diagnosis and management of HIV-positive patients.Rev Esp Med Nucl Imagen Mol (Engl Ed). 2022 Sep-Oct;41(5):275-283. doi: 10.1016/j.remnie.2021.10.005. Epub 2021 Nov 15. Rev Esp Med Nucl Imagen Mol (Engl Ed). 2022. PMID: 34794914
Cited by
-
Cocaine regulates antiretroviral therapy CNS access through pregnane-x receptor-mediated drug transporter and metabolizing enzyme modulation at the blood brain barrier.Fluids Barriers CNS. 2024 Jan 10;21(1):5. doi: 10.1186/s12987-023-00507-3. Fluids Barriers CNS. 2024. PMID: 38200564 Free PMC article.
References
-
- Anthony IC, Bell JE. Paul RS NC, Valcour V, Tasima KT. Neuropathological findings associated with long-term HAART . HIV and the brain: new challenges in the modern era . Totowa, NJ: Humana Press; 2009. 1–19.
-
- Heaton RK, Franklin DR Jr, Deutsch R, Letendre S, Ellis RJ, Casaletto K, et al. CHARTER Group. Neurocognitive change in the era of HIV combination antiretroviral therapy: the longitudinal CHARTER study . Clin Infect Dis 2015; 60:473–480.
-
- Sakamoto M, Marcotte TD, Umlauf A, Franklin D Jr, Heaton RK, Ellis RJ, et al. CHARTER Group. Concurrent classification accuracy of the HIV dementia scale for HIV-associated neurocognitive disorders in the CHARTER Cohort . J Acquir Immune Defic Syndr 2013; 62:36–42.
-
- Eden A, Marcotte TD, Heaton RK, Nilsson S, Zetterberg H, Fuchs D, et al. Increased intrathecal immune activation in virally suppressed HIV-1 infected patients with neurocognitive impairment . PLoS One 2016; 11:e0157160.
-
- Peluso MJ, Meyerhoff DJ, Price RW, Peterson J, Lee E, Young AC, et al. Cerebrospinal fluid and neuroimaging biomarker abnormalities suggest early neurological injury in a subset of individuals during primary HIV infection . J Infect Dis 2013; 207:1703–1712.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical